Shape Memory Hydrogels – A Novel Material for Treating Age-related Degenerative Conditions of the Spine
Abstract
Hydrogels are water-insoluble hydrophilic polymers used in a wide range of medical products such as, drug delivery, tissue replacement, heart surgery, gynaecology, ophthalmology, plastic surgery and orthopaedic surgery. These polymers exhibit low toxicity, reduced tissue adherence, and are highly biocompatible. A class of hydrogels, hydrolysed polyacrylonitriles, possess unique shape memory properties, which, when combined with biodurability, mechanical strength and viscoelasticity make them ideal for treating certain degenerative conditions of the spine. Animal and other in vitro studies have shown that the hydrogel is biocompatible and well tolerated by host tissues. This article focuses on two specific indications in spine surgery that demonstrate the potential of hydrogel-based technology to provide significant treatment advantages.Shape memory hydrogel, hydrolysed polyacrylonitrile, spinal stenosis, degenerative disc disease, biocompatibility, minimally invasive surgery
Hydrogels are able to absorb large quantities of water relative to their initial weight because of their intrinsic hydrophilicity. As a result of this propensity to imbibe large quantities of water, the material can be implanted into the body in a collapsed, low-volume, dehydrated state and then expanded in vivo through absorption of body fluids to assume a different shape comprising a much greater volume. Given that the composition by mass of the expanded polymer is principally water and/or body-derived fluids, the swollen object is highly biocompatible, producing minimal inflammation following implantation.
Although many hydrogels have been developed based on various chemistries, hydrolysed polyacrylonitrile (HPAN) has been extensively studied and used in the formulation of contact lenses, drug delivery, gynaecological and orthopaedic implants.1,2 This group of thermoplastic hydrogels is based on acrylic multiblock copolymers. A heterogeneous reaction of the hydrophobic base polymer polyacrylonitrile with sodium hydroxide produces a water-soluble block copolymer that upon phase separation yields crystalline clusters of hydrophobic nitrile functional groups and amorphous hydrophilic water-binding domains. The hydrogel is produced through a simple chemical reaction using no monomers, cross-linkers, catalysts or other toxic residuals.3
Advantageous properties of the HPAN block copolymer include biocompatibility and biodurability. HPAN also exhibits similar elasticity and tensile strength compared with tissues such as vitreous body, cartilage and the nucleus pulposus of the intervertebral disc. The elasticity of the hydrogel can also be controlled by adjusting the chemistry and the water content, allowing the material to be used in various applications such as replacement of the aforementioned tissues.
The shape memory property of the hydrogel is a unique attribute that provides treatment options in situations where insertion dimensions are crucial. These properties are particularly well suited to indications in minimally invasive spine surgery wherein the collapsed, minimised, insertion form of the hydrogel configured to a particular shape, transforms into a larger and different functional shape upon implantation. In this instance, the minimised shape facilitates insertion with little tissue damage and the fully hydrated state allows the implant to function as either a nucleus augmentation implant or an interspinous spacer (see Figure 1). In vivo expanding hydrogel implants in a nucleus augmentation (left) and interspinous spacer (right) application.
Prior to clinical introduction, hydrogel implants were subjected to an extensive battery of in vitro and in vivo animal tests to evaluate the safety and functional properties of the material. The in vitro and animal tests included but were not limited to acute and chronic toxicity, genotoxicity, systemic toxicity, irritation, and intramuscular implantation testing. All testing was conducted using Good Laboratory Practices (GLP) at an accredited independent laboratory.
- Ray CD, The PDN prosthetic disc-nucleus, Eur Spine J, 2002;11(Suppl.):137s–42s.
- Klara PM, Ray CD, Artificial nucleus replacement: clinical experience, Spine, 2002;27(12):1374–7.
- Hermenau S, Prewett A, Ramachandran R, The biochemistry of spinal implants: short- and long-term considerations. In: Yue JJ, Guyer RD, Johnson JP, et al., The Comprehensive Treatment of the Aging Spine, Philadelphia, PA: Elsevier Saunders, 2011;459–65.
- Bibby SR, Urban JP, Effect of nutrient deprivation on the viability of intervertebral disc cells, Eur Spine J, 2004;13:695–701.
- Spivak JM, Degenerative lumbar spinal stenosis, J Bone Joint Surg Am, 1998;80:1053–66.
- Wang J, Zhou Y, Zhang ZF, et al., Minimally invasive or open transforaminal lumbar interbody fusion as revision surgery for patients previously treated by open discectomy and decompression of the lumber spine, Eur Spine J, 2011;20:623–8.
- Genevay S, Atlas SJ, Lumbar spinal stenosis, Best Pract Res Clin Rheumatol, 2010;24:253–65.
- Bono CM, Vaccaro AR, Interspinous process devices in the lumbar spine, J Spinal Disord Tech, 2007;20:255–61.
- Kim DH, Tantorski M, Shaw J, et al., Occult spinous process fractures associated with interspinous process spacers, Spine, 2011;16:E1080–5.










